• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

载脂蛋白 E4 加剧α-突触核蛋白的种子活性，并导致路易体痴呆型阿尔茨海默病的神经毒性。

APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer's disease with Lewy body pathology.

机构信息

Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA.

Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, FL, 32224, USA.

出版信息

Acta Neuropathol. 2022 Jun;143(6):641-662. doi: 10.1007/s00401-022-02421-8. Epub 2022 Apr 26.

DOI:10.1007/s00401-022-02421-8
PMID:35471463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9107450/
Abstract

Approximately half of Alzheimer's disease (AD) brains have concomitant Lewy pathology at autopsy, suggesting that α-synuclein (α-SYN) aggregation is a regulated event in the pathogenesis of AD. Genome-wide association studies revealed that the ε4 allele of the apolipoprotein E (APOE4) gene, the strongest genetic risk factor for AD, is also the most replicated genetic risk factor for Lewy body dementia (LBD), signifying an important role of APOE4 in both amyloid-β (Aβ) and α-SYN pathogenesis. How APOE4 modulates α-SYN aggregation in AD is unclear. In this study, we aimed to determine how α-SYN is associated with AD-related pathology and how APOE4 impacts α-SYN seeding and toxicity. We measured α-SYN levels and their association with other established AD-related markers in brain samples from autopsy-confirmed AD patients (N = 469), where 54% had concomitant LB pathology (AD + LB). We found significant correlations between the levels of α-SYN and those of Aβ40, Aβ42, tau and APOE, particularly in insoluble fractions of AD + LB. Using a real-time quaking-induced conversion (RT-QuIC) assay, we measured the seeding activity of soluble α-SYN and found that α-SYN seeding was exacerbated by APOE4 in the AD cohort, as well as a small cohort of autopsy-confirmed LBD brains with minimal Alzheimer type pathology. We further fractionated the soluble AD brain lysates by size exclusion chromatography (SEC) ran on fast protein liquid chromatography (FPLC) and identified the α-SYN species (~ 96 kDa) that showed the strongest seeding activity. Finally, using human induced pluripotent stem cell (iPSC)-derived neurons, we showed that amplified α-SYN aggregates from AD + LB brain of patients with APOE4 were highly toxic to neurons, whereas the same amount of α-SYN monomer was not toxic. Our findings suggest that the presence of LB pathology correlates with AD-related pathologies and that APOE4 exacerbates α-SYN seeding activity and neurotoxicity, providing mechanistic insight into how APOE4 affects α-SYN pathogenesis in AD.

摘要

大约有一半的阿尔茨海默病（AD）大脑在尸检时同时存在路易体病理学，这表明α-突触核蛋白（α-SYN）聚集是 AD 发病机制中的一个受调控事件。全基因组关联研究表明，载脂蛋白 E（APOE）基因的 ε4 等位基因是 AD 最强的遗传风险因素，也是路易体痴呆（LBD）最具复制性的遗传风险因素，这表明 APOE4 在淀粉样蛋白-β（Aβ）和 α-SYN 发病机制中都起着重要作用。APOE4 如何调节 AD 中的 α-SYN 聚集尚不清楚。在这项研究中，我们旨在确定 α-SYN 如何与 AD 相关的病理学相关，以及 APOE4 如何影响 α-SYN 接种和毒性。我们测量了尸检证实的 AD 患者（n=469）大脑样本中的 α-SYN 水平及其与其他已建立的 AD 相关标志物的关联，其中 54%的患者同时存在 LB 病理学（AD+LB）。我们发现 α-SYN 水平与 Aβ40、Aβ42、tau 和 APOE 水平之间存在显著相关性，特别是在 AD+LB 的不溶性部分。使用实时震颤诱导转化（RT-QuIC）测定法，我们测量了可溶性 α-SYN 的接种活性，发现 APOE4 在 AD 队列以及一小部分尸检证实的具有最小阿尔茨海默病类型病理学的 LBD 大脑中加剧了 α-SYN 接种。我们进一步通过快速蛋白质液相色谱（FPLC）上的大小排阻色谱（SEC）对可溶性 AD 脑裂解物进行分级，并鉴定出具有最强接种活性的 α-SYN 物种（~96 kDa）。最后，使用人诱导多能干细胞（iPSC）衍生的神经元，我们表明来自 AD+LB 脑的放大的 α-SYN 聚集体对神经元具有高度毒性，而相同量的 α-SYN 单体没有毒性。我们的研究结果表明，LB 病理学的存在与 AD 相关病理学相关，APOE4 加剧了 α-SYN 的接种活性和神经毒性，为 APOE4 如何影响 AD 中的 α-SYN 发病机制提供了机制上的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0e/9107450/8db250b1ead4/401_2022_2421_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0e/9107450/f5c58561f321/401_2022_2421_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0e/9107450/6fcbfff57cd7/401_2022_2421_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0e/9107450/a7a80a65c1cc/401_2022_2421_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0e/9107450/7124a9919c90/401_2022_2421_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0e/9107450/92910f85d223/401_2022_2421_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0e/9107450/aec443ae6805/401_2022_2421_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0e/9107450/37e454a89327/401_2022_2421_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0e/9107450/945954938a3c/401_2022_2421_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0e/9107450/8db250b1ead4/401_2022_2421_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0e/9107450/f5c58561f321/401_2022_2421_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0e/9107450/6fcbfff57cd7/401_2022_2421_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0e/9107450/a7a80a65c1cc/401_2022_2421_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0e/9107450/7124a9919c90/401_2022_2421_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0e/9107450/92910f85d223/401_2022_2421_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0e/9107450/aec443ae6805/401_2022_2421_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0e/9107450/37e454a89327/401_2022_2421_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0e/9107450/945954938a3c/401_2022_2421_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0e/9107450/8db250b1ead4/401_2022_2421_Fig9_HTML.jpg

相似文献

1
APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer's disease with Lewy body pathology.载脂蛋白 E4 加剧α-突触核蛋白的种子活性，并导致路易体痴呆型阿尔茨海默病的神经毒性。
Acta Neuropathol. 2022 Jun;143(6):641-662. doi: 10.1007/s00401-022-02421-8. Epub 2022 Apr 26.
2
Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.神经退行性疾病伴随的蛋白病普遍存在，与年龄相关，与 APOE4 相关。
Brain. 2018 Jul 1;141(7):2181-2193. doi: 10.1093/brain/awy146.
3
α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients.阿尔茨海默病和路易体痴呆患者红细胞中的α-突触核蛋白异源二聚体。
J Alzheimers Dis. 2021;80(2):885-893. doi: 10.3233/JAD-201038.
4
Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease.α-突触核蛋白亚型的异质性及其在路易体病和阿尔茨海默病皮质脑组织裂解物中的表达。
Neuropathol Appl Neurobiol. 2019 Oct;45(6):597-608. doi: 10.1111/nan.12531. Epub 2018 Dec 3.
5
APOE4 exacerbates α-synuclein pathology and related toxicity independent of amyloid.载脂蛋白E4（APOE4）会加剧α-突触核蛋白病变及相关毒性，且与淀粉样蛋白无关。
Sci Transl Med. 2020 Feb 5;12(529). doi: 10.1126/scitranslmed.aay1809.
6
Misfolded α-Synuclein in Autosomal Dominant Alzheimer's Disease.常染色体显性阿尔茨海默病中的错误折叠的 α-突触核蛋白。
J Alzheimers Dis. 2024;97(3):1091-1096. doi: 10.3233/JAD-230919.
7
Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.路易体病中 tau 病理学的认知和病理影响。
Ann Neurol. 2019 Feb;85(2):259-271. doi: 10.1002/ana.25392. Epub 2019 Jan 7.
8
CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders.脑脊液 tau 和 β-淀粉样蛋白可预测尸检路易体病中的脑突触核蛋白病。
Neurology. 2018 Mar 20;90(12):e1038-e1046. doi: 10.1212/WNL.0000000000005166. Epub 2018 Feb 21.
9
Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer's disease.路易体病与阿尔茨海默病的海马亚区病理负担。
Neuropathol Appl Neurobiol. 2020 Dec;46(7):707-721. doi: 10.1111/nan.12659. Epub 2020 Sep 24.
10
Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.嗅球中的tau病理与Braak分期、路易体病理和载脂蛋白ε4相关。
Neuropathol Appl Neurobiol. 2003 Oct;29(5):503-10. doi: 10.1046/j.1365-2990.2003.00453.x.

引用本文的文献

1
Comorbidities and apolipoprotein E genotypes of patients with mild cognitive impairment in transition to Alzheimer's disease.向阿尔茨海默病转变的轻度认知障碍患者的共病情况及载脂蛋白E基因型
J Alzheimers Dis Rep. 2025 Sep 12;9:25424823251353209. doi: 10.1177/25424823251353209. eCollection 2025 Jan-Dec.
2
Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein.路易体痴呆：探索淀粉样β蛋白、tau蛋白和α-突触核蛋白的生物标志物及致病相互作用
Mol Neurodegener. 2025 Aug 12;20(1):90. doi: 10.1186/s13024-025-00879-0.
3
Alpha-synuclein seeding amplification assays in Lewy body dementia: a brief review.

本文引用的文献

1
TDP-43 Pathology in Alzheimer's Disease.阿尔茨海默病中的 TDP-43 病理学。
Mol Neurodegener. 2021 Dec 20;16(1):84. doi: 10.1186/s13024-021-00503-x.
2
Neuropathology and molecular diagnosis of Synucleinopathies.神经病理学和神经核蛋白病的分子诊断。
Mol Neurodegener. 2021 Dec 18;16(1):83. doi: 10.1186/s13024-021-00501-z.
3
FRET-based assay for intracellular evaluation of α-synuclein aggregation inhibitors.基于荧光共振能量转移的检测方法用于细胞内α-突触核蛋白聚集抑制剂的评价。
路易体痴呆中的α-突触核蛋白种子扩增检测：简要综述
Mol Neurodegener. 2025 Jul 1;20(1):77. doi: 10.1186/s13024-025-00868-3.
4
"Proteinjury": a universal pathological mechanism mediated by cerebrospinal fluid in neurodegeneration and trauma.“蛋白质损伤”：一种由脑脊液介导的、在神经退行性变和创伤中普遍存在的病理机制。
Front Cell Dev Biol. 2025 May 20;13:1593122. doi: 10.3389/fcell.2025.1593122. eCollection 2025.
5
Genetic risk and plasma biomarkers of dementia with Lewy bodies in a Chinese population.中国人群中路易体痴呆的遗传风险和血浆生物标志物
NPJ Parkinsons Dis. 2025 May 15;11(1):128. doi: 10.1038/s41531-025-00988-z.
6
Cortical microstructural abnormalities in dementia with Lewy bodies and their associations with Alzheimer's disease copathologies.路易体痴呆中的皮质微结构异常及其与阿尔茨海默病共病的关联。
NPJ Parkinsons Dis. 2025 May 12;11(1):124. doi: 10.1038/s41531-025-00944-x.
7
Distinct patterns of cognitive traits in extreme old age and Alzheimer's disease.高龄与阿尔茨海默病患者认知特征的不同模式。
Alzheimers Dement. 2025 Apr;21(4):e70155. doi: 10.1002/alz.70155.
8
The role of on cognitive impairment in Parkinson's disease and Parkinsonisms.[具体内容]对帕金森病和帕金森综合征认知障碍的作用。 需注意，原文中“on cognitive impairment”前似乎缺失了关键信息。
Front Neurosci. 2025 Feb 20;19:1515374. doi: 10.3389/fnins.2025.1515374. eCollection 2025.
9
Association of CSF α-synuclein seed amplification assay positivity with disease progression and cognitive decline: A longitudinal Alzheimer's Disease Neuroimaging Initiative study.脑脊液α-突触核蛋白种子扩增检测阳性与疾病进展及认知衰退的关联：一项阿尔茨海默病神经影像学倡议纵向研究
Alzheimers Dement. 2024 Dec;20(12):8444-8460. doi: 10.1002/alz.14276. Epub 2024 Oct 20.
10
Modeling Lewy body disease with triplication iPSC-derived cortical organoids and identifying therapeutic drugs.使用三重复制 iPSC 衍生的大脑类器官模拟路易体病并鉴定治疗药物。
Sci Adv. 2024 Sep 13;10(37):eadk3700. doi: 10.1126/sciadv.adk3700. Epub 2024 Sep 11.
J Neurochem. 2021 Dec;159(5):901-912. doi: 10.1111/jnc.15528. Epub 2021 Nov 8.
4
Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease.全基因组生存研究鉴定出帕金森病认知进展的新型突触位点和多基因评分。
Nat Genet. 2021 Jun;53(6):787-793. doi: 10.1038/s41588-021-00847-6. Epub 2021 May 6.
5
The docking of synaptic vesicles on the presynaptic membrane induced by α-synuclein is modulated by lipid composition.α-突触核蛋白诱导的突触小泡在突触前膜上的对接受脂质组成的调节。
Nat Commun. 2021 Feb 10;12(1):927. doi: 10.1038/s41467-021-21027-4.
6
Impact of the apolipoprotein E ε4 allele on early Parkinson's disease progression.载脂蛋白Eε4等位基因对早期帕金森病进展的影响。
Parkinsonism Relat Disord. 2021 Feb;83:66-70. doi: 10.1016/j.parkreldis.2021.01.004. Epub 2021 Jan 12.
7
APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids.载脂蛋白 E4 加剧了阿尔茨海默病患者 iPSC 衍生脑类器官中的突触损失和神经退行性变。
Nat Commun. 2020 Nov 2;11(1):5540. doi: 10.1038/s41467-020-19264-0.
8
Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's Disease.帕金森病认知和运动进展的全基因组关联研究。
Mov Disord. 2021 Feb;36(2):424-433. doi: 10.1002/mds.28342. Epub 2020 Oct 28.
9
How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology.这些构象特异性的α-突触核蛋白抗体的特异性如何？使用具有不同结构和形态的α-突触核蛋白单体、纤维和寡聚体的经过充分表征的制剂，对 16 种α-突触核蛋白构象特异性抗体进行了表征和验证。
Neurobiol Dis. 2020 Dec;146:105086. doi: 10.1016/j.nbd.2020.105086. Epub 2020 Sep 22.
10
Blinded RT-QuIC Analysis of α-Synuclein Biomarker in Skin Tissue From Parkinson's Disease Patients.帕金森病患者皮肤组织中 α-突触核蛋白生物标志物的盲法 RT-QuIC 分析。
Mov Disord. 2020 Dec;35(12):2230-2239. doi: 10.1002/mds.28242. Epub 2020 Sep 22.